Tonix Pharmaceuticals Holding Corp (TNXP) returns
Tonix Pharmaceuticals Holding returns over 10 years
$1,000 invested in Tonix Pharmaceuticals Holding ten years ago was worth $0.00 at the close on October 30, 2026, with dividends reinvested: an average return of -100.0% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -47.6% | — | $523.61 | -0.9% |
| 3 months | -49.5% | — | $505.45 | +2.1% |
| Year to date | -67.3% | — | $326.50 | +11.7% |
| 1 year | -71.8% | — | $282.39 | +12.4% |
| 3 years | -99.7% | -85.9% | $2.78 | +88.5% |
| 5 years | -100.0% | -89.3% | $0.01 | +76.0% |
| 10 years | -100.0% | -100.0% | $0.00 | +316.6% |
Tonix Pharmaceuticals Holding return by calendar year
| Year | TNXP | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -67.3% | +11.7% | -79.0% |
| 2025 | -52.6% | +17.7% | -70.4% |
| 2024 | -97.4% | +24.9% | -122.3% |
| 2023 | -83.5% | +26.2% | -109.6% |
| 2022 | -96.6% | -18.2% | -78.4% |
| 2021 | -47.0% | +28.7% | -75.8% |
| 2020 | -42.3% | +18.4% | -60.7% |
| 2019 | -94.7% | +31.2% | -125.9% |
| 2018 | -93.6% | -4.6% | -89.1% |
| 2017 | -26.6% | +21.7% | -48.3% |
| 2016 | -93.9% | +12.0% | -105.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: TNXP financials
No forecast, no recommendation. This page describes Tonix Pharmaceuticals Holding Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.